Effects of cardiotoxin III on NF-κB function, proliferation, and apoptosis in human breast MCF-7 cancer cells

Oncology Research

Volumn 17, Issue 7, 2009, Pages 311-321

  Chiu, Chien Chih ^a   Lin, Kuei Li ^a   Chien, Ching Ming ^a   Chang, Long Sen ^b   Lin, Shinne Ren ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cardiotoxin III; MCF 7 cells; NF B

Indexed keywords

CARDIOTOXIN III, NAJA NAJA ATRA; CASPASE; COBROTOXIN; CYTOCHROME C; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; SNAKE VENOM; X LINKED INHIBITOR OF APOPTOSIS; XIAP PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CYTOSOL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MITOCHONDRION; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; COBRA CARDIOTOXIN PROTEINS; COBRA VENOMS; CYTOCHROMES C; CYTOSOL; FEMALE; HUMANS; I-KAPPA B KINASE; MITOCHONDRIA; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 65649150091     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009787721186     Document Type: Article

References (39)

1. Kaufmann, S. H.; Earnshaw, W. C. Induction of apoptosis by cancer chemotherapy. Exp. Cell. Res. 256:42-49; 2000.
2. Robertson, J. D.; Orrenius, S. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit. Rev. Toxicol. 30:609-627; 2000.
3. Kaufmann, S. H.; Hengartner, M. O. Programmed cell death: Alive and well in the new millennium. Trends Cell Biol. 11:526-534; 2001.
4. Reed, J. C. Apoptosis-regulating proteins as targets for drug discovery. Trends. Mol. Med. 7:314-319; 2001.
5. Cohen, G. M. Caspases: The executioners of apoptosis. Biochem. J. 326(Pt. 1):1-16; 1997.
6. Shi, Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9:459-470; 2002. (Pubitemid 34273778)
7. Adams, J. M.; Cory, S. The Bcl-2 protein family: Arbiters of cell survival. Science 281:1322-1326; 1998. (Pubitemid 28406819)
8. Anto, R. J.; Mukhopadhyay, A.; Denning, K.; Aggarwal, B. B. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: Its suppression by ectopic expression of Bcl-2 and Bcl-XL. Carcinogenesis 23:143-150; 2002.
9. Antonsson, B.; Martinou, J. C. The Bcl-2 protein family. Exp. Cell Res. 256:50-57; 2000.
10. Salvesen, G. S.; Dixit, V. M. Caspases: Intracellular signaling by proteolysis. Cell 91:443-446; 1997.
11. Baichwal, V. R.; Baeuerle, P. A. Activate NFκB or die? Curr. Biol. 7:R94-96; 1997.
12. Shishodia, S.; Aggarwal, B. B. Nuclear factorκB activation: A question of life or death. J. Biochem. Mol. Biol. 35:28-40; 2002.
13. Chen, Z. J.; Parent, L.; Maniatis, T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862; 1996. (Pubitemid 26106855)
14. Ghosh, S.; Karin, M. Missing pieces in the NF-κB puzzle. Cell 109(Suppl.):S81-96; 2002.
15. Karin, M.; Ben-Neriah, Y. Phosphorylation meets ubiquitination: The control of NF-κB activity. Annu. Rev. Immunol. 18:621-663; 2000.
16. Salvatore, C.; Camarda, G.; Maggi, C. A.; Goso, C.; Manzini, S.; Binaschi, M. NF-κB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780. Int. J. Oncol. 27:799-806; 2005.
17. Weldon, C. B.; Burow, M. E.; Rolfe, K. W.; Clayton, J. L.; Jaffe, B. M.; Beckman, B. S. NFκB-mediated chemoresistance in breast cancer cells. Surgery 130:143-150; 2001.
18. Hideshima, T.; Chauhan, D.; Richardson, P.; Mitsiades, C.; Mitsiades, N.; Hayashi, T.; Munshi, N.; Dang, L.; Castro, A.; Palombella, V.; Adams, J.; Anderson, K. C. NFκB as a therapeutic target in multiple myeloma. J. Biol. Chem. 277:16639-16647; 2002.
19. Dufton, M. J.; Hider, R. C. Structure and pharmacology of elapid cytotoxins. Pharmacol Ther. 36:1-40; 1988.
20. Chien, K. Y.; Huang, W. N.; Jean, J. H.; Wu, W. G. Fusion of sphingomyelin vesicles induced by proteins from Taiwan cobra (Naja naja atra) venom. Interactions of zwitterionic phospholipids with cardiotoxin analogues. J. Biol. Chem. 266:3252-3259; 1991.
21. Chiou, S. H.; Raynor, R. L.; Zheng, B.; Chambers, T. C.; Kuo, J. F. Cobra venom cardiotoxin (cytotoxin) isoforms and neurotoxin: Comparative potency of protein kinase C inhibition and cancer cell cytotoxicity and modes of enzyme inhibition. Biochemistry 32:2062-2067; 1993.
22. Detolla, L. J.; Stump, K. C.; Russell, R.; Viskatis, L. J.; Vidal, J. G.; Newman, R. A.; Etcheverry, M. A. Toxicity of the novel animal-derived anticancer agent, VRCTC-310: Acute and subchronic studies in beagle dogs. Toxicology 99:31-46; 1995.
23. Guo, M. P.; Wang, Q. C.; Liu, G. F. Pharmacokinetics of cytotoxin from Chinese cobra (Naja naja atra) venom. Toxicon 31:339-343; 1993.
24. Newman, R. A.; Vidal, J. C.; Viskatis, L. J.; Johnson, J.; Etcheverry, M. A. VRCTC-310 - a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest New Drugs 11:151-159; 1993.
25. Yang, S. H.; Chien, C. M.; Lu, M. C.; Lu, Y. J.; Wu, Z. Z.; Lin, S. R. Cardiotoxin III induces apoptosis in K562 cells through a mitochondrial-mediated pathway. Clin. Exp. Pharmacol. Physiol. 32:515-520; 2005.
26. Yang, S. H.; Lu, M. C.; Chien, C. M.; Tsai, C. H.; Lu, Y. J.; Hour, T. C.; Lin, S. R. Induction of apoptosis in human leukemia K562 cells by cardiotoxin III. Life Sci. 76:2513-2522; 2005.
27. Lin, S. R.; Chang, L. S.; Chang, K. L. Separation and structure-function studies of Taiwan cobra cardiotoxins. J. Protein Chem. 21:81-86; 2002.
28. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184:39-51; 1995.
29. Hofer-Warbinek, R.; Schmid, J. A.; Stehlik, C.; Binder, B. R.; Lipp, J.; De Martin, R. Activation of NFκB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J. Biol. Chem. 275:22064-22068; 2000.
30. Green, D. R.; Reed, J. C. Mitochondria and apoptosis. Science 281:1309-1312; 1998.
31. Jiang, X.; Wang, X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275:31199-31203; 2000.
32. Bhardwaj, A.; Sethi, G.; Vadhan-Raj, S.; Bueso-Ramos, C.; Takada, Y.; Gaur, U.; Nair, A. S.; Shishodia, S.; Aggarwal, B. B. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through downregulation of STAT3 and nuclear factor-κB-regulated anti-apoptotic and cell survival gene products in human multiple myeloma cells. Blood 109:2293-2302; 2007.
33. Bharti, A. C.; Donato, N.; Singh, S.; Aggarwal, B. B. Curcumin (diferuloylmethane) down-regulates the constitutive activation of NFκB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101:1053-1062; 2003.
34. Dhandapani, K. M.; Mahesh, V. B.; Brann, D. W. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NF-κB transcription factors. J. Neurochem. 102:522-538; 2007.
35. Freudlsperger, C.; Greten, J.; Schumacher, U. Curcumin induces apoptosis in human neuroblastoma cells via inhibition of NF-κB. Anticancer Res. 28:209-214; 2008. (Pubitemid 351362903)
36. Ni, H.; Ergin, M.; Huang, Q.; Qin, J. Z.; Amin, H. M.; Martinez, R. L.; Saeed, S.; Barton, K.; Alkan, S. Analysis of expression of nuclear factor kappa B (NFκB) in multiple myeloma: Downregulation of NFκB induces apoptosis. Br. J. Haematol. 115:279-286; 2001.
37. Pahl, H. L. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18:6853-6866; 1999.
38. Pastorino, J. G.; Chen, S. T.; Tafani, M.; Snyder, J. W.; Farber, J. L. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273:7770-7775; 1998.
39. Yang, J.; Liu, X.; Bhalla, K.; Kim, C. N.; Ibrado, A. M.; Cai, J.; Peng, T. I.; Jones, D. P.; Wang, X. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132; 1997. (Pubitemid 27097312)